36 min listen
Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
ratings:
Length:
35 minutes
Released:
Apr 25, 2024
Format:
Podcast episode
Description
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA). Credit available for this activity expires: 4/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu
Released:
Apr 25, 2024
Format:
Podcast episode
Titles in the series (100)
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations: Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME